Gene: MAML2 ×
Source: BEFREE ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4598633
rs4598633
MAML2
0.010 GeneticVariation BEFREE Rs7115578 polymorphism had a lower susceptibility to glioma in males (OR = 0.68, P=0.034), while rs4598633 variant with a higher risk in females (OR = 1.66, P=0.016). 31652449

2019
dbSNP: rs485842
rs485842
MAML2
0.010 GeneticVariation BEFREE MAML2 rs7938889 and rs485842 polymorphisms were associated with the reduced risk of glioma (OR = 0.69, P=0.023; and OR = 0.81, P=0.032, respectively). 31652449

2019
dbSNP: rs7115578
rs7115578
MAML2
0.010 GeneticVariation BEFREE Additionally, rs7115578 AG genotype represented a poorer prognosis of glioma (HR = 1.24, P=0.033) and astrocytoma (log-rank P=0.037, HR = 1.31, P=0.036). 31652449

2019
dbSNP: rs7938889
rs7938889
MAML2
0.010 GeneticVariation BEFREE MAML2 rs7938889 and rs485842 polymorphisms were associated with the reduced risk of glioma (OR = 0.69, P=0.023; and OR = 0.81, P=0.032, respectively). 31652449

2019